Perils of the Pathologic Complete Response

被引：42

作者：

Rose, Brent S. ^{[1
]}

Winer, Eric P. ^{[2
]}

Mamon, Harvey J. ^{[2
,3
]}

机构：

[1] Harvard Radiat Oncol Program, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 33期

关键词：

OPERABLE BREAST-CANCER; DOSE-INTENSIFIED CHEMOTHERAPY; SURGICAL ADJUVANT BREAST; ADVANCED RECTAL-CANCER; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; DARBEPOETIN ALPHA; ANTICANCER DRUGS; RANDOMIZED-TRIAL; PREPARE TRIAL;

D O I：

10.1200/JCO.2016.68.1718

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3959 / U40

页数：5

共 43 条

[1]

[Anonymous], BIOSTATISTICS

[2] Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial [J].

Baselga, Jose ;

Bradbury, Ian ;

Eidtmann, Holger ;

Di Cosimo, Serena ;

de Azambuja, Evandro ;

Aura, Claudia ;

Gomez, Henry ;

Dinh, Phuong ;

Fauria, Karine ;

Van Dooren, Veerle ;

Aktan, Gursel ;

Goldhirsch, Aron ;

Chang, Tsai-Wang ;

Horvath, Zsolt ;

Coccia-Portugal, Maria ;

Domont, Julien ;

Tseng, Ling-Min ;

Kunz, Georg ;

Sohn, Joo Hyuk ;

Semiglazov, Vladimir ;

Lerzo, Guillermo ;

Palacova, Marketa ;

Probachai, Volodymyr ;

Pusztai, Lajos ;

Untch, Michael ;

Gelber, Richard D. ;

Piccart-Gebhart, Martine .

LANCET, 2012, 379 (9816) :633-640

[3] Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J].

Bear, HD ;

Anderson, S ;

Smith, RE ;

Geyer, CE ;

Mamounas, EP ;

Fisher, B ;

Brown, AM ;

Robidoux, A ;

Margolese, R ;

Kahlenberg, MS ;

Paik, S ;

Soran, A ;

Wickerham, DL ;

Wolmark, N .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2019-2027

[4] Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies [J].

Berruti, Alfredo ;

Amoroso, Vito ;

Gallo, Fabio ;

Bertaglia, Valentina ;

Simoncini, Edda ;

Pedersini, Rebecca ;

Ferrari, Laura ;

Bottini, Alberto ;

Bruzzi, Paolo ;

Sormani, Maria Pia .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (34) :3883-U288

[5] Neoadjuvant Therapy in Breast Cancer as a Basis for Drug Approval [J].

Berry, Donald A. ;

Hudis, Clifford A. .

JAMA ONCOLOGY, 2015, 1 (07) :875-876

[6] What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question? [J].

Bonnetain, F. ;

Bosset, J. F. ;

Gerard, J. P. ;

Calais, G. ;

Conroy, T. ;

Mineur, L. ;

Bouche, O. ;

Maingon, P. ;

Chapet, O. ;

Radosevic-Jelic, L. ;

Methy, N. ;

Collette, L. .

EUROPEAN JOURNAL OF CANCER, 2012, 48 (12) :1781-1790

[7] Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: An update of the initial randomized study population and data of additional patients treated with the same regimen [J].

Buzdar, Aman U. ;

Valero, Vicente ;

Ibrahim, Nuhad K. ;

Francis, Deborah ;

Broglio, Kristine R. ;

Theriault, Richard L. ;

Pusztai, Lajos ;

Green, Marjorie C. ;

Singletary, Sonja E. ;

Hunt, Kelly K. ;

Sahin, Aysegul A. ;

Esteva, Francisco ;

Symmans, William F. ;

Ewer, Michael S. ;

Buchholz, Thomas A. ;

Hortobagyi, Gabriel N. .

CLINICAL CANCER RESEARCH, 2007, 13 (01) :228-233

[8] Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer [J].

Buzdar, AU ;

Ibrahim, NK ;

Francis, D ;

Booser, DJ ;

Thomas, ES ;

Theriault, RL ;

Pusztai, L ;

Green, MC ;

Arun, BK ;

Giordano, SH ;

Cristofanilli, M ;

Frye, DK ;

Smith, TL ;

Hunt, KK ;

Singletary, SE ;

Sahin, AA ;

Ewer, MS ;

Buchholz, TA ;

Berry, D ;

Hortobagyi, GN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3676-3685

[9] Molecular Origins of Cancer Molecular Basis of Metastasis [J].

Chiang, Anne C. ;

Massague, Joan .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (26) :2814-2823

[10] Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes [J].

Cocconi, G ;

Di Blasio, B ;

Boni, C ;

Bisagni, G ;

Rondini, E ;

Bella, MA ;

Leonardi, F ;

Savoldi, L ;

Vallisneri, C ;

Camisa, R ;

Bruzzi, P .

ANNALS OF ONCOLOGY, 2005, 16 (09) :1469-1476

← 1 2 3 4 5 →